Motif ID Motif Logo Scanned Score Distribution Frequency of Motif Replicability Score Evolutionary Conservation Score Gene Targets Gene Ontology of CpGMM targets
CG_ffipsc1911_promoter_n_RM_12_39_8 logo scan 6 0.8 3.08E-04 ADH5, GCLM response to nitrosative stress [BP]
CG_ffipsc1911_promoter_n_RM_12_74_11 logo scan 4 0.8 1.27E-04 KDELR2 KDEL sequence binding [MF]
CG_ffipsc1911_promoter_n_RM_12_145_8 logo scan 4 0.8 3.10E-04 CDO1 response to glucagon stimulus [BP]
CG_ffipsc1911_promoter_n_RM_12_37_6 logo scan 4 0.6 3.00E-04 TBX15, NODAL embryonic cranial skeleton morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_12_180_2 logo scan 5 1.0 1.16E-04 CALCRL cellular response to sucrose stimulus [BP],
adrenomedullin receptor activity [MF]
CG_ffipsc1911_promoter_n_RM_12_60_6 logo scan 5 0.8 2.60E-04 FGFR1, SALL1 embryonic limb morphogenesis [BP],
outer ear morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_12_176_6 logo scan 6 1.0 2.96E-04 MKI67, PEAK1, MAD2L2 DNA metabolic process [BP],
cell migration [BP],
negative regulation of mitotic anaphase-promoting complex activity [BP]
CG_ffipsc1911_promoter_n_RM_12_93_5 logo scan 5 0.6 2.98E-04 GCLM, BCL2L1 regulation of mitochondrial membrane potential [BP],
glutamate-cysteine ligase catalytic subunit binding [MF],
positive regulation of glutamate-cysteine ligase activity [BP]
CG_ffipsc1911_promoter_n_RM_12_59_10 logo scan 7 1.0 4.74E-04 NOTCH1, NCAPD3, GDF2 regulation of extracellular matrix assembly [BP],
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP],
blood vessel morphogenesis [BP],
positive regulation of BMP signaling pathway [BP],
venous endothelial cell differentiation [BP],
nuclear condensin complex [CC],
branching morphogenesis of an epithelial tube [BP]
CG_ffipsc1911_promoter_n_RM_12_107_3 logo scan 4 0.6 1.98E-04 ALG12, GLO1, POU4F1 dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [MF],
alpha-1,6-mannosyltransferase activity [MF],
lactoylglutathione lyase activity [MF],
proprioception involved in equilibrioception [BP]
CG_ffipsc1911_promoter_n_RM_12_147_4 logo scan 4 0.8 2.88E-04 SIN3A, POLD4 DNA replication [BP]
CG_ffipsc1911_promoter_n_RM_12_242_8 logo scan 6 1.0 2.93E-04 SRI, CACNB1 T-tubule [CC]
CG_ffipsc1911_promoter_n_RM_12_62_5 logo scan 2 0.4 2.11E-04 NKX3-2, GBGT1 globoside alpha-N-acetylgalactosaminyltransferase activity [MF],
organ formation [BP]
CG_ffipsc1911_promoter_n_RM_14_14_2 logo scan 2 0.4 4.78E-04 SIX5, SIX1, SIX2, SIX4 embryonic skeletal system morphogenesis [BP],
middle ear morphogenesis [BP],
myoblast migration [BP],
positive regulation of ureteric bud formation [BP],
kidney development [BP],
regulation of synaptic growth at neuromuscular junction [BP],
regulation of branch elongation involved in ureteric bud branching [BP],
sequence-specific DNA binding [MF],
metanephric mesenchyme development [BP],
embryonic cranial skeleton morphogenesis [BP],
branching involved in ureteric bud morphogenesis [BP],
positive regulation of branching involved in ureteric bud morphogenesis [BP],
thymus development [BP]
CG_ffipsc1911_promoter_n_RM_12_105_5 logo scan 5 1.0 3.82E-04 LMF1, ARFGEF1, KRIT1 regulation of establishment of cell polarity [BP],
protein glycosylation in Golgi [BP]
CG_ffipsc1911_promoter_n_RM_16_9_7 logo scan 9 1.0 2.58E-04 PODXL, GBX1, BARHL2, ONECUT1, SCRIB, HOXA1, FOXN4, EDF1 sequence-specific DNA binding [MF],
epithelial tube formation [BP],
asymmetric protein localization [BP]
CG_ffipsc1911_promoter_n_RM_12_33_5 logo scan 6 0.8 4.11E-04 FOXL2, SLC25A11, TFAP2A female somatic sex determination [BP],
optic cup structural organization [BP],
optic vesicle morphogenesis [BP],
menstruation [BP],
embryonic eye morphogenesis [BP],
oxoglutarate:malate antiporter activity [MF]
CG_ffipsc1911_promoter_n_RM_12_174_7 logo scan 3 0.6 3.16E-04 GLRX2, ADH5, TXN peptide disulfide oxidoreductase activity [MF],
response to redox state [BP]
CG_ffipsc1911_promoter_n_RM_12_190_6 logo scan 4 0.8 3.03E-04 PKD1, EIF5A2, FN1, LGR4 genitalia development [BP],
metanephric nephron tubule morphogenesis [BP],
metanephric distal tubule morphogenesis [BP],
calcium-independent cell-matrix adhesion [BP],
polyamine homeostasis [BP],
cell-matrix adhesion [BP]
CG_ffipsc1911_promoter_n_RM_12_195_6 logo scan 3 0.6 2.69E-04 COQ3, SLC30A3 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF],
zinc transporting ATPase activity [MF],
3-demethylubiquinone-9 3-O-methyltransferase activity [MF],
hexaprenyldihydroxybenzoate methyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_274_7 logo scan 3 0.6 3.50E-04 PRICKLE1, DOC2B, MSRB1, SMC1A cohesin core heterodimer [CC],
calcium ion-dependent exocytosis of neurotransmitter [BP],
methionine-R-sulfoxide reductase activity [MF],
negative regulation of cardiac muscle cell myoblast differentiation [BP]
CG_ffipsc1911_promoter_n_RM_12_23_8 logo scan 3 0.6 2.93E-04 DLG4 dendritic spine morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_12_278_15 logo scan 7 0.8 5.21E-04 NEUROG1, SHARPIN, ASCL2 apoptotic nuclear changes [BP],
E-box binding [MF]
CG_ffipsc1911_promoter_n_RM_12_141_4 logo scan 4 0.8 2.48E-04 NUDT18 GDP catabolic process [BP],
8-oxo-dGDP phosphatase activity [MF],
8-oxo-GDP phosphatase activity [MF],
dADP catabolic process [BP],
dGDP catabolic process [BP],
8-hydroxy-dADP phosphatase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_259_5 logo scan 6 1.0 3.72E-04 HEG1, SALL1 ventricular septum development [BP]
CG_ffipsc1911_promoter_n_RM_14_18_6 logo scan 9 0.8 2.69E-04 MYO1C, SLC27A5 basal plasma membrane [CC]
CG_ffipsc1911_promoter_n_RM_12_160_10 logo scan 5 0.8 3.76E-04 LPCAT1, LPCAT3 phosphatidylcholine acyl-chain remodeling [BP],
1-acylglycerophosphocholine O-acyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_168_8 logo scan 6 0.8 4.28E-04 ST6GALNAC4, CYB561 transmembrane electron transfer carrier [MF],
(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_68_4 logo scan 3 0.6 2.62E-04 KCNE3, KIF5B, CLIP3 positive regulation of establishment of protein localization to plasma membrane [BP],
regulation of potassium ion transport [BP]
CG_ffipsc1911_promoter_n_RM_12_12_8 logo scan 3 0.6 2.88E-04 ATP13A3, MAP3K6, CSAD, CSNK1D, DGKI, RABEP2, ABCA3, CLK1, MTOR, TOP3A, DALRD3 sulfur amino acid catabolic process [BP],
ATP binding [MF]
CG_ffipsc1911_promoter_n_RM_12_111_6 logo scan 5 1.0 2.06E-04 CLK2, TNK2 protein serine/threonine/tyrosine kinase activity [MF],
protein tyrosine kinase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_5_6 logo scan 4 0.8 3.21E-04 UBC, DUOX2 hypothalamus gonadotrophin-releasing hormone neuron development [BP],
adenohypophysis morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_12_143_6 logo scan 9 1.0 3.36E-04 CRYGS, BMP4 BMP signaling pathway involved in renal system segmentation [BP],
bud dilation involved in lung branching [BP],
negative regulation of metanephric comma-shaped body morphogenesis [BP],
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP],
negative regulation of glomerulus development [BP],
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP],
negative regulation of mesenchymal cell proliferation involved in ureter development [BP],
lens development in camera-type eye [BP],
negative regulation of cell proliferation involved in heart morphogenesis [BP],
negative regulation of metanephric S-shaped body morphogenesis [BP],
pulmonary artery endothelial tube morphogenesis [BP],
positive regulation of branching involved in lung morphogenesis [BP],
BMP signaling pathway involved in nephric duct formation [BP],
intermediate mesodermal cell differentiation [BP],
BMP signaling pathway involved in ureter morphogenesis [BP],
ureter epithelial cell differentiation [BP],
positive regulation of cardiac muscle fiber development [BP]
CG_ffipsc1911_promoter_n_RM_12_257_5 logo scan 6 0.8 2.98E-04 TRIM9, AMPH, PIP5K1C synaptic vesicle exocytosis [BP],
synaptic vesicle endocytosis [BP]
CG_ffipsc1911_promoter_n_RM_12_272_2 logo scan 3 0.6 3.49E-04 GCH1, SULT1A2, MFSD10, NACC2, SYNE4, FLT1, RAB27A vascular endothelial growth factor receptor-1 signaling pathway [BP],
GTP cyclohydrolase I activity [MF],
catecholamine metabolic process [BP],
VEGF-A-activated receptor activity [MF],
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP],
placental growth factor-activated receptor activity [MF],
tetracycline transporter activity [MF],
cytotoxic T cell degranulation [BP],
integral to nuclear outer membrane [CC],
VEGF-B-activated receptor activity [MF],
tetracycline transport [BP],
7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP]
CG_ffipsc1911_promoter_n_RM_12_166_5 logo scan 4 0.8 3.34E-04 SALL1, ABCB6, BRF1 transcription factor TFIIIB complex [CC],
heme-transporting ATPase activity [MF],
inductive cell-cell signaling [BP]
CG_ffipsc1911_promoter_n_RM_12_21_9 logo scan 4 0.8 2.48E-04 NOP14, TERT, LDB1 Noc4p-Nop14p complex [CC],
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP],
histone H3-K4 acetylation [BP],
telomeric template RNA reverse transcriptase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_53_5 logo scan 3 0.6 3.14E-04 WNT11, ARHGAP27 positive regulation of Rac GTPase activity [BP],
positive regulation of Ras GTPase activity [BP]
CG_ffipsc1911_promoter_n_RM_12_29_5 logo scan 4 0.6 2.80E-04 FZD5, JAG2 thymic T cell selection [BP],
T cell differentiation in thymus [BP]
CG_ffipsc1911_promoter_n_RM_12_194_7 logo scan 7 1.0 2.80E-04 GRIK5, GRIK3 kainate selective glutamate receptor activity [MF],
extracellular-glutamate-gated ion channel activity [MF],
ionotropic glutamate receptor activity [MF]
CG_ffipsc1911_promoter_n_RM_12_236_16 logo scan 4 0.8 3.50E-04 DTYMK, OAT, SALL1, DKK3, EEA1 adrenal gland development [BP],
synaptic vesicle to endosome fusion [BP],
serine-pyruvate aminotransferase complex [CC],
nucleoside phosphate kinase activity [MF],
nucleoside monophosphate phosphorylation [BP],
ornithine-oxo-acid transaminase activity [MF],
inductive cell-cell signaling [BP]
CG_ffipsc1911_promoter_n_RM_12_235_7 logo scan 5 0.8 3.62E-04 MYL3, MYH11 muscle myosin complex [CC],
structural constituent of muscle [MF]
CG_ffipsc1911_promoter_n_RM_16_7_1 logo scan 2 0.4 1.72E-04 RTN4 regulation of branching morphogenesis of a nerve [BP]
CG_ffipsc1911_promoter_n_RM_12_10_4 logo scan 5 0.8 1.91E-04 SOCS1, ADPGK, SOCS3, GAMT negative regulation of insulin receptor signaling pathway [BP],
guanidinoacetate N-methyltransferase activity [MF],
regulation of interferon-gamma-mediated signaling pathway [BP],
kinase inhibitor activity [MF],
regulation of type I interferon-mediated signaling pathway [BP],
protein kinase inhibitor activity [MF],
regulation of growth [BP],
JAK-STAT cascade involved in growth hormone signaling pathway [BP],
ADP-specific glucokinase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_254_4 logo scan 4 0.8 2.34E-04 ZRANB3, IMPAD1 DNA rewinding [BP],
3'-nucleotidase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_283_7 logo scan 5 1.0 3.28E-04 WNT5A, BBC3, WNT9A, HOXA7 positive regulation of thymocyte apoptotic process [BP],
anterior/posterior pattern specification [BP]
CG_ffipsc1911_promoter_n_RM_12_115_4 logo scan 2 0.4 3.26E-04 CBS, GCLC, CDC42EP3 cysteine metabolic process [BP],
regulation of blood vessel size [BP],
cystathionine beta-synthase activity [MF],
cysteine biosynthetic process via cystathionine [BP],
cytoskeletal regulatory protein binding [MF],
homocysteine catabolic process [BP],
transsulfuration [BP],
cysteine biosynthetic process from serine [BP],
hydrogen sulfide biosynthetic process [BP],
sulfur amino acid metabolic process [BP],
glutamate-cysteine ligase complex [CC]
CG_ffipsc1911_promoter_n_RM_12_276_5 logo scan 4 0.6 3.70E-04 EPB41L3, GRIK3, IFT20, GPR179 dendrite terminus [CC],
dendrite [CC],
protein localization to plasma membrane [BP]
CG_ffipsc1911_promoter_n_RM_14_29_2 logo scan 3 0.4 4.40E-04 TAOK3, EARS2 glutamate-tRNA(Gln) ligase activity [MF],
protein kinase inhibitor activity [MF],
glutamate-tRNA ligase activity [MF]
CG_ffipsc1911_promoter_n_RM_14_33_2 logo scan 3 0.6 3.18E-04 ZNF442, ZNF443, ZNF799, ZNF823, HIST1H1A, HIST1H1B, ZNF44 nucleosome [CC],
DNA binding [MF]
CG_ffipsc1911_promoter_n_RM_12_249_4 logo scan 6 1.0 2.46E-04 FOXA2, NOTCH1, SAV1, PIEZO1 ventricular septum morphogenesis [BP],
lung epithelial cell differentiation [BP],
cardiac muscle cell proliferation [BP],
lung development [BP],
positive regulation of cell-cell adhesion mediated by integrin [BP],
branching morphogenesis of an epithelial tube [BP]
CG_ffipsc1911_promoter_n_RM_12_151_3 logo scan 2 0.4 2.70E-04 SRXN1, CRLF1, MAD1L1 sulfiredoxin activity [MF],
mitotic telophase [BP],
negative regulation of motor neuron apoptotic process [BP]
CG_ffipsc1911_promoter_n_RM_12_100_7 logo scan 3 0.4 3.21E-04 ACD DNA polymerase binding [MF],
positive regulation of single-stranded telomeric DNA binding [BP]
CG_ffipsc1911_promoter_n_RM_12_85_3 logo scan 2 0.4 2.56E-04 CLDN19, CLDN6, NACA calcium-independent cell-cell adhesion [BP],
nascent polypeptide-associated complex [CC]
CG_ffipsc1911_promoter_n_RM_12_260_4 logo scan 4 0.6 3.05E-04 GRM8, SGMS1, DCUN1D3, XRCC2 response to gamma radiation [BP],
group III metabotropic glutamate receptor activity [MF],
sphingomyelin synthase activity [MF],
ceramide cholinephosphotransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_16_1_2 logo scan 2 0.4 4.86E-04 ZNF737, ZNF681, H2AFX, HIST1H1B, ZNF117, HIST3H2A, ZNF91, ZNF43 nucleosome assembly [BP],
nucleosome [CC],
DNA binding [MF],
nucleus [CC]
CG_ffipsc1911_promoter_n_RM_12_44_3 logo scan 3 0.6 1.99E-04 SLC12A6, PTCH1, NFKBIA, DUSP16, SLC23A1 MAPK phosphatase export from nucleus, leptomycin B sensitive [BP],
positive regulation of cholesterol efflux [BP],
dehydroascorbic acid transport [BP],
MAPK export from nucleus [BP],
cellular hypotonic salinity response [BP],
hindlimb morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_16_3_1 logo scan 1 0.2 2.06E-04 ZNF626, ZNF681, ZNF737, ZNF506, ZNF708 transcription, DNA-dependent [BP],
DNA binding [MF],
regulation of transcription, DNA-dependent [BP],
zinc ion binding [MF]
CG_ffipsc1911_promoter_n_RM_12_8_7 logo scan 4 0.8 4.10E-04 GNG12, ADCY9 cellular response to glucagon stimulus [BP]
CG_ffipsc1911_promoter_n_RM_12_83_5 logo scan 2 0.4 5.89E-04 PDGFB negative regulation of phosphatidylinositol biosynthetic process [BP],
positive regulation of hyaluronan biosynthetic process [BP],
paracrine signaling [BP],
metanephric glomerular endothelium development [BP],
metanephric glomerular mesangial cell development [BP],
positive regulation of glomerular filtration [BP],
cellular response to mycophenolic acid [BP],
positive regulation of metanephric mesenchymal cell migration [BP],
positive regulation of glomerular mesangial cell proliferation [BP],
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_119_9 logo scan 6 1.0 2.76E-04 EEF1D, MLH3, RPL22L1 translation [BP],
protein localization [BP]
CG_ffipsc1911_promoter_n_RM_12_9_8 logo scan 6 1.0 3.30E-04 ABCA2, FBXO5, ATP8B1 spindle assembly involved in female meiosis I [BP],
ATP catabolic process [BP],
regulation of intracellular cholesterol transport [BP],
inhibition of mitotic anaphase-promoting complex activity [BP]
CG_ffipsc1911_promoter_n_RM_12_165_11 logo scan 3 0.6 2.66E-04 NKX6-1, RAD54B, AKAP8L, TLE3, TSPYL5, DIP2C, KIAA0368, EVX2, LATS2, ZNF582, RANBP3, FKBP3, ZNF823, EFCAB6, STRADA, IRX3, ZNF667, TGFB1 germ cell migration [BP],
nucleus [CC]
CG_ffipsc1911_promoter_n_RM_12_45_10 logo scan 5 0.8 3.75E-04 PDGFB, FKBP7, FOXRED2, GLT25D2 endoplasmic reticulum lumen [CC]
CG_ffipsc1911_promoter_n_RM_14_21_3 logo scan 5 0.8 3.01E-04 GCLM, MYO1C, TBX18 glutamate-cysteine ligase catalytic subunit binding [MF],
myosin I complex [CC],
negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
positive regulation of glutamate-cysteine ligase activity [BP],
positive regulation of vascular endothelial growth factor signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_135_9 logo scan 4 0.6 2.30E-04 NR2C1, PTK2, BAG6, NRL, MEIS3, SIM1, UBQLN4, GATAD2B, HOXA4, FOXL2, OVOL2, MYT1L, MAFB, IRX3, NR3C2 neural fold formation [BP],
negative regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
sequence-specific DNA binding transcription factor activity [MF],
regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
sequence-specific DNA binding [MF],
embryo development [BP]
CG_ffipsc1911_promoter_n_RM_14_17_2 logo scan 4 0.6 7.44E-05 NACA, HSPD1 negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP],
positive regulation of T cell mediated immune response to tumor cell [BP],
B cell cytokine production [BP],
positive regulation of skeletal muscle tissue growth [BP],
nascent polypeptide-associated complex [CC]
CG_ffipsc1911_promoter_n_RM_12_1_9 logo scan 4 0.8 3.31E-04 TGFB1, PHIP, ANKLE2, PPP1CA, MAD2L2 positive regulation of protein dephosphorylation [BP],
protein dephosphorylation [BP],
positive regulation of peptidyl-threonine phosphorylation [BP],
positive regulation of peptidyl-serine phosphorylation [BP],
lens fiber cell differentiation [BP]
CG_ffipsc1911_promoter_n_RM_12_252_4 logo scan 5 1.0 2.80E-04 DAD1, DPM3, ALG3 protein N-linked glycosylation via asparagine [BP]
CG_ffipsc1911_promoter_n_RM_12_231_6 logo scan 5 1.0 1.84E-04 NCAPD3, FGF8, HOXB3 thyroid gland development [BP],
nuclear condensin complex [CC]
CG_ffipsc1911_promoter_n_RM_14_15_4 logo scan 2 0.4 3.78E-04 ARC, ONECUT1 endoderm development [BP]
CG_ffipsc1911_promoter_n_RM_12_102_12 logo scan 4 0.8 2.27E-04 IPMK, HSPA5, MTHFSD, CAMK2D, NFKBIA, CCT4, NADKD1, CDK5, CDK6, NVL, RPS6KA5, AMPH synaptic vesicle endocytosis [BP],
cyclin-dependent protein kinase activity [MF],
peptidyl-serine phosphorylation [BP],
cyclin-dependent protein kinase holoenzyme complex [CC],
negative regulation of lipid storage [BP],
kinase activity [MF],
ATP binding [MF]
CG_ffipsc1911_promoter_n_RM_12_279_4 logo scan 6 1.0 3.35E-04 KCTD1, SFRP1, EEF1A1, TLE1, TTF1, DPF1, TIA1, ATXN3, SFRP2 negative regulation of BMP signaling pathway [BP],
negative regulation of epithelial to mesenchymal transition [BP],
Wnt-protein binding [MF],
Wnt receptor signaling pathway involved in somitogenesis [BP],
negative regulation of cell growth [BP],
cellular response to X-ray [BP],
negative regulation of cytokine biosynthetic process [BP],
cellular protein metabolic process [BP],
regulation of transcription, DNA-dependent [BP],
transcription, DNA-dependent [BP],
negative regulation of peptidyl-tyrosine phosphorylation [BP],
convergent extension involved in axis elongation [BP],
positive regulation of fat cell differentiation [BP],
Wnt-activated receptor activity [MF],
transcription from RNA polymerase I promoter [BP],
negative regulation of Wnt receptor signaling pathway [BP],
negative regulation of planar cell polarity pathway involved in axis elongation [BP],
negative regulation of JUN kinase activity [BP],
planar cell polarity pathway involved in neural tube closure [BP]
CG_ffipsc1911_promoter_n_RM_12_268_8 logo scan 4 0.8 3.90E-04 KDELR1, MGAT1, DENND5A, SEC16A, STC2, CHPF, VAC14, B4GALT6, RPN1 Golgi membrane [CC],
Golgi apparatus [CC],
protein N-linked glycosylation via asparagine [BP]
CG_ffipsc1911_promoter_n_RM_14_7_3 logo scan 2 0.4 4.30E-04 HYAL1 hyaluranon cable [CC]
CG_ffipsc1911_promoter_n_RM_12_87_5 logo scan 3 0.6 2.68E-04 CLCN7, CLCN2 voltage-gated chloride channel activity [MF]
CG_ffipsc1911_promoter_n_RM_12_137_9 logo scan 7 1.0 1.76E-04 ALK, STAT5B, HLA-C, HLA-B, HRAS, AKT1, YBX2, GAREM, PYY MHC class I receptor activity [MF],
cell proliferation [BP],
epidermal growth factor receptor signaling pathway [BP],
integral to lumenal side of endoplasmic reticulum membrane [CC],
cell surface receptor signaling pathway [BP],
glycogen cell differentiation involved in embryonic placenta development [BP],
MHC class I protein complex [CC],
T cell homeostasis [BP],
positive regulation of sequence-specific DNA binding transcription factor activity [BP],
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP],
cellular response to epidermal growth factor stimulus [BP],
ER to Golgi transport vesicle membrane [CC],
transmembrane receptor protein tyrosine kinase signaling pathway [BP],
translational attenuation [BP]
CG_ffipsc1911_promoter_n_RM_12_212_4 logo scan 3 0.6 4.06E-04 HEYL, COL16A1 AF-1 domain binding [MF],
collagen type XVI [CC]
CG_ffipsc1911_promoter_n_RM_12_46_8 logo scan 3 0.6 3.15E-04 CRLF1, LBX2, TSHZ3, SFRP5, HOXA11, ZFP36L2, TBX5, CDKN2A ureteric bud development [BP],
developmental growth [BP],
ureteric peristalsis [BP],
transcription, DNA-dependent [BP],
sequence-specific DNA binding [MF],
sequence-specific DNA binding transcription factor activity [MF],
negative regulation of Wnt receptor signaling pathway involved in digestive tract morphogenesis [BP],
cell migration involved in coronary vasculogenesis [BP],
DNA binding [MF],
negative regulation of motor neuron apoptotic process [BP]
CG_ffipsc1911_promoter_n_RM_12_139_5 logo scan 5 0.8 3.00E-04 COL12A1 collagen type XII [CC]
CG_ffipsc1911_promoter_n_RM_14_13_5 logo scan 7 1.0 2.96E-04 STK3, GANAB, MMAB, FLT4 glucan 1,3-alpha-glucosidase activity [MF],
positive regulation of JNK cascade [BP],
glucosidase II complex [CC],
cob(I)yrinic acid a,c-diamide adenosyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_96_3 logo scan 2 0.4 2.02E-04 SLC7A10 D-alanine transport [BP]
CG_ffipsc1911_promoter_n_RM_12_112_8 logo scan 6 1.0 2.84E-04 SH3YL1, SLC6A4, SLC13A4, STK3, SLC26A5, ABCB6, CPT1A negative regulation of organ growth [BP],
sulfate transport [BP],
secondary active sulfate transmembrane transporter activity [MF],
primitive hemopoiesis [BP],
integral to mitochondrial outer membrane [CC],
positive regulation of gene expression [BP],
regulation of ruffle assembly [BP]
CG_ffipsc1911_promoter_n_RM_12_205_5 logo scan 5 0.8 1.91E-04 ALG12 dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [MF],
alpha-1,6-mannosyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_203_6 logo scan 4 0.8 2.38E-04 DPYSL3, CBX4 phosphoprotein binding [MF]
CG_ffipsc1911_promoter_n_RM_12_218_5 logo scan 4 0.8 4.13E-04 PAK1, FERMT2 filamentous actin [CC]
CG_ffipsc1911_promoter_n_RM_12_90_3 logo scan 2 0.4 2.45E-04 NKX2-5, FGFR2 proepicardium development [BP],
positive regulation of voltage-gated calcium channel activity [BP],
ventricular septum morphogenesis [BP],
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP],
regulation of cardiac muscle cell proliferation [BP],
fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP],
cardiac muscle cell proliferation [BP],
ventricular cardiac muscle tissue morphogenesis [BP],
Purkinje myocyte differentiation [BP],
coronal suture morphogenesis [BP],
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP],
atrioventricular node cell fate commitment [BP],
outflow tract septum morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_14_20_2 logo scan 5 0.8 5.01E-04 ITPK1, SCTR inositol tetrakisphosphate 1-kinase activity [MF],
inositol-1,3,4-trisphosphate 6-kinase activity [MF],
secretin receptor activity [MF],
inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_171_3 logo scan 3 0.6 3.52E-04 MESP1 negative regulation of endodermal cell fate specification [BP],
positive regulation of Notch signaling pathway involved in heart induction [BP],
cardiac atrium formation [BP],
cardioblast migration to the midline involved in heart field formation [BP],
cardioblast anterior-lateral migration [BP],
sinus venosus morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_12_52_8 logo scan 6 0.8 3.24E-04 SOX15, EVX2, FEV, OTP, RAX, SIM1 negative regulation of striated muscle tissue development [BP],
sequence-specific DNA binding transcription factor activity [MF],
hypothalamus development [BP]
CG_ffipsc1911_promoter_n_RM_12_154_3 logo scan 4 0.8 3.31E-04 GSC, DKK4 negative regulation of Wnt receptor signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_92_7 logo scan 5 0.6 3.62E-04 MYO1F, DPYSL3, MYO1A, TYROBP neutrophil activation involved in immune response [BP],
cortical actin cytoskeleton [CC],
filamentous actin [CC]
CG_ffipsc1911_promoter_n_RM_12_75_5 logo scan 5 0.8 3.10E-04 NCOR1, NAGA, CSNK1D circadian regulation of gene expression [BP],
spindle microtubule [CC],
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP],
spindle assembly [BP],
alpha-N-acetylgalactosaminidase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_116_5 logo scan 4 0.8 2.61E-04 NRARP, TBX20 patterning of blood vessels [BP]
CG_ffipsc1911_promoter_n_RM_12_125_4 logo scan 3 0.6 2.89E-04 ACLY citrate lyase complex [CC],
ATP citrate synthase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_122_6 logo scan 5 0.8 3.26E-04 NCOR1, WNT11, OTX2, EXTL2 endoderm development [BP],
alpha-1,4-N-acetylgalactosaminyltransferase activity [MF],
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc1911_promoter_n_RM_12_140_10 logo scan 8 1.0 2.38E-04 BAD, BCAR1, ADAM17, NUP62 epidermal growth factor receptor signaling pathway [BP],
positive regulation of epidermal growth factor receptor signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_225_5 logo scan 6 1.0 2.98E-04 HOXA1 optokinetic behavior [BP],
abducens nerve formation [BP]
CG_ffipsc1911_promoter_n_RM_12_164_5 logo scan 3 0.6 3.27E-04 SDF4 zymogen granule exocytosis [BP]
CG_ffipsc1911_promoter_n_RM_12_262_6 logo scan 5 1.0 2.70E-04 SDF4, E2F8, UCN positive regulation of DNA replication [BP],
zymogen granule exocytosis [BP],
gastric emptying [BP],
cell cycle comprising mitosis without cytokinesis [BP]
CG_ffipsc1911_promoter_n_RM_12_28_9 logo scan 2 0.4 3.43E-04 CDK6, CDK5, SIAH2 cyclin-dependent protein kinase activity [MF],
cyclin-dependent protein kinase holoenzyme complex [CC],
neuron projection [CC]
CG_ffipsc1911_promoter_n_RM_14_10_2 logo scan 2 0.4 4.09E-04 ALG9 dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF],
dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_214_4 logo scan 2 0.4 2.65E-04 NCOR1, GBA, PAX6 commitment of neuronal cell to specific neuron type in forebrain [BP],
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP],
pancreatic A cell development [BP],
forebrain-midbrain boundary formation [BP],
termination of signal transduction [BP],
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc1911_promoter_n_RM_12_88_3 logo scan 3 0.6 4.55E-04 FOXL2, PRKDC, E2F7 transcription factor complex [CC]
CG_ffipsc1911_promoter_n_RM_12_169_6 logo scan 5 0.8 2.97E-04 SLC18A1, LPCAT1, CLU, AKT1 neurotransmitter transport [BP],
positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
positive regulation of protein catabolic process [BP]
CG_ffipsc1911_promoter_n_RM_12_54_7 logo scan 4 0.6 3.95E-05 ADAM8 alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex [CC],
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [BP],
positive regulation of neutrophil extravasation [BP],
positive regulation of fibronectin-dependent thymocyte migration [BP],
activation of MAPK activity involved in innate immune response [BP],
dense core granule membrane [CC],
alpha9-beta1 integrin-ADAM8 complex [CC],
positive regulation of eosinophil migration [BP]
CG_ffipsc1911_promoter_n_RM_12_238_9 logo scan 4 0.6 1.65E-04 PAF1 histone monoubiquitination [BP]
CG_ffipsc1911_promoter_n_RM_12_267_4 logo scan 2 0.4 3.86E-04 TACR3 tachykinin receptor activity [MF]
CG_ffipsc1911_promoter_n_RM_12_263_5 logo scan 6 1.0 3.95E-04 TFAP2A, SDC1, MOGS, MTHFR, PITX2, PRICKLE1 negative regulation of cardiac muscle cell myoblast differentiation [BP],
RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF],
RNA polymerase II transcription coactivator activity [MF],
mannosyl-oligosaccharide glucosidase activity [MF],
superior vena cava morphogenesis [BP],
odontogenesis [BP],
ribonucleoprotein complex binding [MF],
prolactin secreting cell differentiation [BP],
optic cup structural organization [BP],
optic vesicle morphogenesis [BP],
embryonic camera-type eye development [BP],
subthalamic nucleus development [BP],
core promoter proximal region sequence-specific DNA binding [MF],
outflow tract morphogenesis [BP],
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF],
RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription [MF],
methylenetetrahydrofolate reductase (NADPH) activity [MF],
neural crest cell development [BP]
CG_ffipsc1911_promoter_n_RM_12_250_12 logo scan 3 0.6 1.91E-04 ARFGEF1 positive regulation of protein glycosylation in Golgi [BP]
CG_ffipsc1911_promoter_n_RM_12_281_7 logo scan 2 0.4 3.44E-04 GNB2L1, TNFRSF10A, ARFGEF1, WNT9A, NLRC4, SETD2, LMF1 embryonic skeletal system morphogenesis [BP],
protein glycosylation in Golgi [BP],
regulation of establishment of cell polarity [BP],
activation of cysteine-type endopeptidase activity involved in apoptotic process [BP],
mesoderm morphogenesis [BP],
embryonic skeletal joint development [BP]
CG_ffipsc1911_promoter_n_RM_12_184_4 logo scan 3 0.6 2.03E-04 CRAT carnitine O-acetyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_84_6 logo scan 2 0.4 3.45E-04 PCYT2, SALL1, TBL1XR1, UBC, PDGFA hypothalamus gonadotrophin-releasing hormone neuron development [BP],
histone deacetylase complex [CC],
inductive cell-cell signaling [BP],
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP],
ethanolamine-phosphate cytidylyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_14_4_2 logo scan 3 0.4 4.94E-04 PRSS27, DLG4, RHBDF2 beta-1 adrenergic receptor binding [MF],
regulation of grooming behavior [BP],
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering [BP],
P2Y1 nucleotide receptor binding [MF],
ADP-activated nucleotide receptor activity [MF],
serine-type endopeptidase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_108_9 logo scan 8 1.0 3.92E-04 FBXW11, FEZF1, UBE2N, ZNF692, IRS1, RNF130, STAT5B, ERF, SALL1, USP28, ZNF563, XPO4, ZNF746 JAK-STAT cascade involved in growth hormone signaling pathway [BP],
olfactory bulb development [BP],
nucleus [CC]
CG_ffipsc1911_promoter_n_RM_12_121_3 logo scan 5 1.0 3.37E-04 RAF1, GTF2E2 activation of MAPKK activity [BP],
MAP kinase kinase kinase activity [MF],
transcription factor TFIIE complex [CC]
CG_ffipsc1911_promoter_n_RM_12_234_7 logo scan 4 0.6 2.72E-04 COL7A1, CALB1, MSRB1 collagen type VII [CC],
metanephric connecting tubule development [BP],
methionine-R-sulfoxide reductase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_127_9 logo scan 8 1.0 2.98E-04 PPP1CA, UBE2N, NELFE, HOXA7, DYM, TIGD7, HIRA UBC13-MMS2 complex [CC],
UBC13-UEV1A complex [CC],
nucleus [CC]
CG_ffipsc1911_promoter_n_RM_12_265_3 logo scan 5 1.0 3.56E-04 SNUPN, TRMT2A, COBL actin filament network formation [BP],
RNA processing [BP],
snRNA import into nucleus [BP]
CG_ffipsc1911_promoter_n_RM_12_50_7 logo scan 3 0.6 3.51E-04 HOXA1, ALAD optokinetic behavior [BP],
abducens nerve formation [BP],
porphobilinogen synthase activity [MF],
lead ion binding [MF]
CG_ffipsc1911_promoter_n_RM_14_2_1 logo scan 4 0.6 1.67E-04 IMPAD1, CERS1, NAGA alpha-N-acetylgalactosaminidase activity [MF],
3'(2'),5'-bisphosphate nucleotidase activity [MF],
sphingolipid metabolic process [BP],
alpha-galactosidase activity [MF],
3'-nucleotidase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_204_3 logo scan 5 0.8 2.71E-04 MYO1C, LSS, PITPNM1 lanosterol synthase activity [MF],
myosin I complex [CC],
lipid particle [CC],
positive regulation of vascular endothelial growth factor signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_200_7 logo scan 7 1.0 2.07E-04 B9D1, CORIN, SASS6, ACTR1A, TUBGCP6, ERAP1 centrosome [CC],
regulation of blood pressure [BP]
CG_ffipsc1911_promoter_n_RM_12_40_4 logo scan 3 0.6 2.57E-04 SLC35B2, WT1 3'-phosphoadenosine 5'-phosphosulfate transport [BP],
3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF],
negative regulation of metanephric glomerular mesangial cell proliferation [BP]
CG_ffipsc1911_promoter_n_RM_12_49_8 logo scan 2 0.4 3.96E-04 CDC37, ANAPC2 regulation of cyclin-dependent protein kinase activity [BP]
CG_ffipsc1911_promoter_n_RM_12_199_4 logo scan 1 0.2 2.27E-04 GDNF postganglionic parasympathetic nervous system development [BP]
CG_ffipsc1911_promoter_n_RM_12_232_5 logo scan 4 0.6 3.36E-04 SRXN1, RNASET2, KDM5B, HID1 sulfiredoxin activity [MF],
extrinsic to Golgi membrane [CC],
histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP],
histone demethylase activity (H3-trimethyl-K4 specific) [MF],
ribonuclease T2 activity [MF],
response to brefeldin A [BP]
CG_ffipsc1911_promoter_n_RM_12_133_6 logo scan 5 1.0 2.03E-04 PODXL, P4HB, TXN2 cell redox homeostasis [BP],
glycerol ether metabolic process [BP],
regulation of microvillus assembly [BP],
protein disulfide oxidoreductase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_156_7 logo scan 3 0.6 3.50E-04 CDK5, HDAC5 response to cocaine [BP],
acetylcholine receptor activator activity [MF]
CG_ffipsc1911_promoter_n_RM_12_134_8 logo scan 3 0.6 4.08E-04 TYROBP neutrophil activation involved in immune response [BP]
CG_ffipsc1911_promoter_n_RM_12_233_3 logo scan 4 0.8 2.25E-04 SLC30A1, ABCB6, COQ3, ANKRA2, SIK1 negative regulation of zinc ion transmembrane import [BP],
heme-transporting ATPase activity [MF],
2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF],
cadmium ion transmembrane transport [BP],
histone deacetylase binding [MF],
3-demethylubiquinone-9 3-O-methyltransferase activity [MF],
detoxification of cadmium ion [BP],
hexaprenyldihydroxybenzoate methyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_16_11_1 logo scan 3 0.6 6.00E-04 RBM19 positive regulation of embryonic development [BP]
CG_ffipsc1911_promoter_n_RM_12_128_7 logo scan 4 0.8 2.32E-04 ENO1, PAX5, STAT5B, HOXA4, L3MBTL4, HOXA1, GATAD2B, ZNF217 motor neuron axon guidance [BP],
sequence-specific DNA binding transcription factor activity [MF]
CG_ffipsc1911_promoter_n_RM_12_80_4 logo scan 4 0.6 3.49E-04 SLC33A1, SLC23A1 acetyl-CoA transporter activity [MF],
dehydroascorbic acid transport [BP],
acetyl-CoA transport [BP]
CG_ffipsc1911_promoter_n_RM_12_113_2 logo scan 2 0.4 3.66E-04 SMAD7, UGT3A1, ABCB6, NKX2-5, UGT3A2 proepicardium development [BP],
positive regulation of voltage-gated calcium channel activity [BP],
ventricular septum morphogenesis [BP],
glucuronosyltransferase activity [MF],
cardiac muscle contraction [BP],
regulation of cardiac muscle contraction [BP],
ventricular cardiac muscle tissue morphogenesis [BP],
heme-transporting ATPase activity [MF],
Purkinje myocyte differentiation [BP],
cardiac muscle tissue morphogenesis [BP],
atrioventricular node cell fate commitment [BP]
CG_ffipsc1911_promoter_n_RM_12_208_6 logo scan 2 0.4 3.09E-04 NAGA, GRM4 alpha-N-acetylgalactosaminidase activity [MF],
presynaptic active zone membrane [CC]
CG_ffipsc1911_promoter_n_RM_12_130_10 logo scan 2 0.4 2.23E-04 CRK, CACNG2, RAB3B, ABCB6, CPT1A regulation of Rac protein signal transduction [BP],
membrane hyperpolarization [BP],
GTP catabolic process [BP],
integral to mitochondrial outer membrane [CC],
regulation of Rho GTPase activity [BP]
CG_ffipsc1911_promoter_n_RM_12_209_6 logo scan 5 1.0 3.95E-04 TENM4 cardiac muscle cell proliferation [BP]
CG_ffipsc1911_promoter_n_RM_12_229_5 logo scan 2 0.4 1.63E-04 MKX, BCOR tendon sheath development [BP],
negative regulation of tooth mineralization [BP],
negative regulation of histone H3-K36 methylation [BP],
negative regulation of histone H3-K4 methylation [BP]
CG_ffipsc1911_promoter_n_RM_12_253_5 logo scan 3 0.6 1.57E-04 DOLK, UCHL5, PLLP, BAG6, SERINC5 proteasome binding [MF],
compact myelin [CC],
myelin sheath [CC],
dolichol kinase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_197_6 logo scan 4 0.6 3.54E-04 DPM3, PCYT2 protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP],
ethanolamine-phosphate cytidylyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_198_6 logo scan 2 0.4 3.30E-04 WNT9A, GNAQ G-protein coupled receptor binding [MF],
glutamate receptor signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_271_7 logo scan 4 0.8 2.25E-04 CSDA, EARS2, DIMT1 glutamate-tRNA(Gln) ligase activity [MF],
18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF],
positive regulation of cytoplasmic translation [BP]
CG_ffipsc1911_promoter_n_RM_12_255_4 logo scan 9 1.0 2.63E-04 TPMT, FOXL2, NCOR1, VAX1, CTTNBP2 female somatic sex determination [BP],
thiopurine S-methyltransferase activity [MF],
menstruation [BP],
brain development [BP],
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc1911_promoter_n_RM_12_163_4 logo scan 7 1.0 2.34E-04 PRICKLE1, ULK2, RAB3A, CLU, SLC18A1, RCHY1 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
negative regulation of collateral sprouting [BP],
clathrin-sculpted monoamine transport vesicle membrane [CC]
CG_ffipsc1911_promoter_n_RM_12_7_6 logo scan 8 0.8 3.91E-04 UROC1, ZRANB3, NFIB negative regulation of mesenchymal cell proliferation involved in lung development [BP],
DNA rewinding [BP],
urocanate hydratase activity [MF],
cerebellar mossy fiber [CC],
Type I pneumocyte differentiation [BP],
negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP],
principal sensory nucleus of trigeminal nerve development [BP]
CG_ffipsc1911_promoter_n_RM_12_239_10 logo scan 3 0.6 1.10E-04 MKI67, MLF2, SIX5, DNASE1L3, DEAF1, SIX1, RRP9, RENBP N-acylglucosamine 2-epimerase activity [MF],
nucleus [CC]
CG_ffipsc1911_promoter_n_RM_12_17_7 logo scan 4 0.8 2.14E-04 CHST10 HNK-1 sulfotransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_217_6 logo scan 3 0.6 5.99E-04 TUBGCP3 polar microtubule [CC]
CG_ffipsc1911_promoter_n_RM_12_196_4 logo scan 4 0.6 3.51E-04 MYO1C, FLT1, SLC35B2 3'-phosphoadenosine 5'-phosphosulfate transport [BP],
vascular endothelial growth factor receptor-1 signaling pathway [BP],
positive regulation of vascular endothelial growth factor signaling pathway [BP],
placental growth factor-activated receptor activity [MF],
VEGF-B-activated receptor activity [MF],
cellular response to vascular endothelial growth factor stimulus [BP],
3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF],
myosin I complex [CC],
VEGF-A-activated receptor activity [MF]
CG_ffipsc1911_promoter_n_RM_12_24_5 logo scan 4 0.8 1.36E-04 TRPT1, RERE tRNA 2'-phosphotransferase activity [MF],
poly-glutamine tract binding [MF]
CG_ffipsc1911_promoter_n_RM_12_224_5 logo scan 5 1.0 2.84E-04 CERS1, CERS2 ceramide biosynthetic process [BP],
sphingosine N-acyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_14_24_3 logo scan 7 0.8 4.03E-04 BARX1, ONECUT1 spleen development [BP]
CG_ffipsc1911_promoter_n_RM_12_124_4 logo scan 2 0.4 3.63E-04 HIST1H1T, HIST1H2BJ, HIST1H2BL nucleosome assembly [BP],
nucleosome [CC]
CG_ffipsc1911_promoter_n_RM_12_172_2 logo scan 5 1.0 2.82E-04 TOP2B, IRS1, GCLM glutamate-cysteine ligase catalytic subunit binding [MF],
protein kinase C binding [MF],
positive regulation of glutamate-cysteine ligase activity [BP]
CG_ffipsc1911_promoter_n_RM_12_226_5 logo scan 5 0.8 1.78E-04 LAMA1 laminin-3 complex [CC]
CG_ffipsc1911_promoter_n_RM_12_251_5 logo scan 3 0.6 2.37E-04 LAMA1 branching involved in salivary gland morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_14_35_1 logo scan 2 0.4 5.62E-04 PPAT amidophosphoribosyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_222_10 logo scan 5 1.0 6.29E-04 COL16A1, POLG2, RPS6KA5, TFAP2A optic vesicle morphogenesis [BP],
histone H2A-S1 phosphorylation [BP],
collagen type XVI [CC],
mitochondrial chromosome [CC],
optic cup structural organization [BP]
CG_ffipsc1911_promoter_n_RM_12_89_5 logo scan 4 0.8 3.33E-04 LSS, ITPK1 inositol tetrakisphosphate 1-kinase activity [MF],
inositol-1,3,4-trisphosphate 6-kinase activity [MF],
lanosterol synthase activity [MF],
inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_19_8 logo scan 4 0.6 2.50E-04 UBXN1, ELAC2, PNKP, RAB3A endonuclease activity [MF],
ATPase binding [MF]
CG_ffipsc1911_promoter_n_RM_12_65_2 logo scan 2 0.4 2.81E-04 PAX6, LTBP2, MAP3K7, PDGFA regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP],
salivary gland morphogenesis [BP],
positive regulation of MAP kinase activity [BP],
commitment of neuronal cell to specific neuron type in forebrain [BP],
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP],
pancreatic A cell development [BP],
forebrain-midbrain boundary formation [BP],
transforming growth factor beta receptor signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_126_7 logo scan 8 1.0 3.84E-04 GAS1 positive regulation of mesenchymal cell proliferation [BP]
CG_ffipsc1911_promoter_n_RM_12_56_7 logo scan 7 1.0 2.56E-04 AGXT2L1, SLC4A11 borate transmembrane transporter activity [MF],
borate transport [BP],
phosphoenolpyruvate-dependent sugar phosphotransferase system [BP],
ethanolamine-phosphate phospho-lyase activity [MF],
borate transmembrane transport [BP]
CG_ffipsc1911_promoter_n_RM_12_183_4 logo scan 4 0.6 2.61E-04 SDC1, EPHA2, JAK1, HYAL2 response to toxin [BP],
negative regulation of protein kinase B signaling cascade [BP],
response to antibiotic [BP]
CG_ffipsc1911_promoter_n_RM_12_129_7 logo scan 4 0.8 3.64E-04 MEFV, ALS2, PTHLH, TCF3, NEUROG2 regulation of endosome size [BP],
mammary gland bud elongation [BP],
E-box binding [MF],
nipple sheath formation [BP],
negative regulation of macrophage inflammatory protein 1 alpha production [BP]
CG_ffipsc1911_promoter_n_RM_12_159_5 logo scan 3 0.4 2.25E-04 GCLM, GNPNAT1, MGEA5 regulation of mitochondrial depolarization [BP],
N-acetylglucosamine metabolic process [BP]
CG_ffipsc1911_promoter_n_RM_14_25_3 logo scan 5 0.6 3.99E-04 SGK1 regulation of cell growth [BP]
CG_ffipsc1911_promoter_n_RM_12_131_6 logo scan 6 0.8 2.33E-04 FOXP1, B3GALNT1, MEOX2, MKX, HOXA7 skeletal muscle tissue development [BP],
galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity [MF],
sequence-specific DNA binding [MF]
CG_ffipsc1911_promoter_n_RM_12_58_5 logo scan 8 1.0 3.40E-04 HIBCH, ADPGK, ITPK1 inositol tetrakisphosphate 1-kinase activity [MF],
inositol-1,3,4-trisphosphate 6-kinase activity [MF],
inositol-1,3,4-trisphosphate 5-kinase activity [MF],
ADP-specific glucokinase activity [MF],
3-hydroxyisobutyryl-CoA hydrolase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_38_4 logo scan 4 0.8 2.97E-04 ACD, HOXA11 embryonic limb morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_12_191_10 logo scan 5 1.0 3.31E-04 MAFB rhombomere 6 development [BP]
CG_ffipsc1911_promoter_n_RM_12_185_4 logo scan 5 1.0 3.57E-04 TFAP4, LATS1 negative regulation of cyclin-dependent protein kinase activity [BP]
CG_ffipsc1911_promoter_n_RM_12_4_4 logo scan 2 0.4 3.47E-04 CBS, CSAD, CSGALNACT1, CHST9 chondroitin sulfate biosynthetic process [BP],
sulfur compound metabolic process [BP],
chondroitin sulfate proteoglycan biosynthetic process [BP],
sulfur amino acid catabolic process [BP],
endochondral ossification [BP]
CG_ffipsc1911_promoter_n_RM_14_23_5 logo scan 6 0.8 2.25E-04 A4GALT lactosylceramide 4-alpha-galactosyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_179_3 logo scan 3 0.6 2.67E-04 BMP4, FOXM1, YBX2, ONECUT1 BMP signaling pathway involved in renal system segmentation [BP],
bud dilation involved in lung branching [BP],
ureter epithelial cell differentiation [BP],
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP],
negative regulation of glomerulus development [BP],
negative regulation of mesenchymal cell proliferation involved in ureter development [BP],
negative regulation of metanephric comma-shaped body morphogenesis [BP],
liver development [BP],
negative regulation of cell proliferation involved in heart morphogenesis [BP],
negative regulation of metanephric S-shaped body morphogenesis [BP],
epithelial cell development [BP],
BMP signaling pathway involved in nephric duct formation [BP],
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP],
endocrine pancreas development [BP],
pulmonary artery endothelial tube morphogenesis [BP],
intermediate mesodermal cell differentiation [BP],
BMP signaling pathway involved in ureter morphogenesis [BP],
translational attenuation [BP],
positive regulation of cardiac muscle fiber development [BP]
CG_ffipsc1911_promoter_n_RM_12_81_7 logo scan 4 0.8 2.09E-04 PNPLA8 phosphatidylethanolamine catabolic process [BP]
CG_ffipsc1911_promoter_n_RM_12_106_9 logo scan 4 0.8 1.84E-04 NKX2-2 ventral spinal cord interneuron fate determination [BP],
core promoter proximal region DNA binding [MF],
type B pancreatic cell fate commitment [BP]
CG_ffipsc1911_promoter_n_RM_12_63_7 logo scan 5 1.0 3.99E-04 PRKAR1B, PRKACA cellular response to glucagon stimulus [BP],
activation of protein kinase A activity [BP],
water transport [BP],
cAMP-dependent protein kinase complex [CC]
CG_ffipsc1911_promoter_n_RM_12_132_9 logo scan 6 1.0 2.09E-04 PKD1, CSDA, KCNK9, HOXA1, TFAP2A optokinetic behavior [BP],
skin development [BP],
positive regulation of cytoplasmic translation [BP],
metanephric nephron development [BP],
metanephric distal tubule morphogenesis [BP],
optic cup structural organization [BP],
optic vesicle morphogenesis [BP],
cochlea development [BP],
abducens nerve formation [BP],
inner ear development [BP],
embryonic cranial skeleton morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_12_206_5 logo scan 4 0.8 3.63E-04 GSS, HOXA1, CS semicircular canal formation [BP],
optokinetic behavior [BP],
abducens nerve formation [BP],
glutathione synthase activity [MF],
citrate (Si)-synthase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_34_4 logo scan 4 0.8 4.23E-04 GNAQ, TWIST1 cell proliferation involved in heart valve development [BP],
embryonic digit morphogenesis [BP],
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP]
CG_ffipsc1911_promoter_n_RM_12_170_3 logo scan 3 0.6 2.18E-04 EGR2 rhombomere 3 formation [BP],
rhombomere 5 formation [BP]
CG_ffipsc1911_promoter_n_RM_14_27_8 logo scan 9 1.0 2.40E-04 RBM22, NUP160 nucleocytoplasmic transporter activity [MF]
CG_ffipsc1911_promoter_n_RM_12_207_6 logo scan 4 0.8 2.23E-04 TAP2, DAP, BRF1, TBX18 negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
positive regulation of antigen processing and presentation of peptide antigen via MHC class I [BP],
transcription factor TFIIIB complex [CC],
cellular response to amino acid starvation [BP],
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [BP],
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [BP]
CG_ffipsc1911_promoter_n_RM_12_243_3 logo scan 2 0.4 2.46E-04 PGR ovulation from ovarian follicle [BP]
CG_ffipsc1911_promoter_n_RM_12_152_7 logo scan 4 0.8 4.04E-04 SOCS3, STAT5B JAK-STAT cascade involved in growth hormone signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_146_6 logo scan 6 1.0 3.14E-04 DLL1, GNB2L1, JAG2 Notch binding [MF],
ion channel inhibitor activity [MF],
Notch receptor processing [BP]
CG_ffipsc1911_promoter_n_RM_12_181_3 logo scan 3 0.6 2.09E-04 DOC2B, CDK6, JUP gamma-catenin-TCF7L2 complex [CC],
structural constituent of cell wall [MF],
calcium ion-dependent exocytosis of neurotransmitter [BP],
cell dedifferentiation [BP]
CG_ffipsc1911_promoter_n_RM_12_161_11 logo scan 6 1.0 3.08E-04 SFRP1, PEAK1, DLL1, PTK2, SALL1, JAK3, CDK6, SIM1 ureteric bud development [BP],
regulation of cell adhesion [BP],
negative regulation of osteoblast differentiation [BP],
regulation of osteoblast differentiation [BP],
osteoblast differentiation [BP],
negative regulation of myeloid cell differentiation [BP],
growth hormone receptor signaling pathway [BP],
non-membrane spanning protein tyrosine kinase activity [MF],
negative regulation of cell differentiation [BP],
regulation of focal adhesion assembly [BP],
positive regulation of cell-matrix adhesion [BP],
positive regulation of cell adhesion [BP],
hematopoietic stem cell differentiation [BP]
CG_ffipsc1911_promoter_n_RM_12_210_11 logo scan 7 1.0 4.92E-04 CRK, EFNB2 ephrin receptor binding [MF],
ephrin receptor signaling pathway [BP]
CG_ffipsc1911_promoter_n_RM_12_246_11 logo scan 4 0.6 3.10E-04 NFIB, SOX30, PBXIP1, KCTD1, TBX18 transcription corepressor activity [MF],
sequence-specific DNA binding RNA polymerase II transcription factor activity [MF],
RNA polymerase II transcription corepressor activity [MF]
CG_ffipsc1911_promoter_n_RM_12_175_4 logo scan 4 0.8 2.81E-04 TCF3 natural killer cell differentiation [BP]
CG_ffipsc1911_promoter_n_RM_12_61_13 logo scan 5 1.0 3.94E-04 POU4F1 proprioception involved in equilibrioception [BP]
CG_ffipsc1911_promoter_n_RM_12_136_3 logo scan 5 0.8 4.45E-04 WNT3, TRIM9 Spemann organizer formation at the anterior end of the primitive streak [BP],
negative regulation of SNARE complex assembly [BP],
synaptic vesicle exocytosis [BP]
CG_ffipsc1911_promoter_n_RM_14_38_2 logo scan 3 0.4 1.90E-04 CLASP1 centrosomal corona [CC],
cortical microtubule cytoskeleton [CC]
CG_ffipsc1911_promoter_n_RM_12_144_4 logo scan 3 0.6 2.30E-04 C5, ADRA2B negative regulation of macrophage chemotaxis [BP],
negative regulation of norepinephrine secretion [BP]
CG_ffipsc1911_promoter_n_RM_12_273_7 logo scan 3 0.6 3.72E-04 EBF3, PICALM, MAD2L2 positive regulation of transcription, DNA-dependent [BP]
CG_ffipsc1911_promoter_n_RM_12_228_8 logo scan 5 0.8 2.24E-04 SLC13A5 succinate transmembrane transporter activity [MF]
CG_ffipsc1911_promoter_n_RM_12_177_4 logo scan 5 0.8 1.99E-04 UBQLN4, BCL2L1 nuclear proteasome complex [CC],
response to cycloheximide [BP],
cytosolic proteasome complex [CC]
CG_ffipsc1911_promoter_n_RM_14_30_2 logo scan 7 1.0 5.52E-04 HOXA5, ALG2 protein glycosylation in endoplasmic reticulum [BP],
cell-cell signaling involved in mammary gland development [BP],
GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_57_9 logo scan 6 1.0 2.55E-04 SIX1, SHH ureter smooth muscle cell differentiation [BP],
metanephric mesenchyme development [BP],
thyroid gland development [BP],
thymus development [BP],
positive regulation of mesenchymal cell proliferation involved in ureter development [BP]
CG_ffipsc1911_promoter_n_RM_12_78_7 logo scan 5 1.0 2.86E-04 ERRFI1 regulation of keratinocyte differentiation [BP]
CG_ffipsc1911_promoter_n_RM_12_30_6 logo scan 8 1.0 3.47E-04 SH3PXD2B, SNX3, MYO10, TBX18 phosphatidylinositol-3-phosphate binding [MF],
positive regulation of cell-cell adhesion [BP]
CG_ffipsc1911_promoter_n_RM_12_284_7 logo scan 5 1.0 1.25E-04 MESP1 negative regulation of endodermal cell fate specification [BP],
positive regulation of Notch signaling pathway involved in heart induction [BP],
cardiac atrium formation [BP],
cardioblast migration to the midline involved in heart field formation [BP],
cardioblast anterior-lateral migration [BP],
sinus venosus morphogenesis [BP]
CG_ffipsc1911_promoter_n_RM_12_193_7 logo scan 8 1.0 2.45E-04 NHP2L1, HACE1, SNRPB, FLNA, NOA1, YWHAZ mitochondrial translation [BP],
gene expression [BP],
Rac GTPase binding [MF]
CG_ffipsc1911_promoter_n_RM_16_4_1 logo scan 3 0.6 9.97E-04 AURKB cleavage furrow formation [BP],
spindle midzone assembly involved in mitosis [BP],
chromosome passenger complex [CC]
CG_ffipsc1911_promoter_n_RM_14_9_3 logo scan 2 0.4 2.93E-04 TCFL5, JUN, ROCK1, BCL11B, CHUK, RAB3A, COL2A1, FEZF1 axonogenesis [BP],
anatomical structure morphogenesis [BP],
epithelial cell morphogenesis [BP],
maintenance of presynaptic active zone structure [BP],
striatal medium spiny neuron differentiation [BP],
regulation of cell differentiation [BP],
leading edge cell differentiation [BP],
axon guidance [BP],
cellular response to potassium ion starvation [BP],
olfactory bulb axon guidance [BP],
collagen type II [CC],
multicellular organismal development [BP],
RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF],
cell differentiation [BP]
CG_ffipsc1911_promoter_n_RM_12_20_4 logo scan 3 0.6 2.63E-04 BAD, NKX3-1, DPP7, DPP9 cysteine-type endopeptidase activator activity involved in apoptotic process [MF],
response to testosterone stimulus [BP],
aminopeptidase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_247_9 logo scan 7 1.0 3.73E-04 ZRANB3, LUZP1 DNA rewinding [BP],
neural fold bending [BP]
CG_ffipsc1911_promoter_n_RM_12_15_5 logo scan 4 0.8 2.49E-04 IFNA2 negative regulation of interleukin-5 secretion [BP],
negative regulation of interleukin-13 secretion [BP]
CG_ffipsc1911_promoter_n_RM_12_256_8 logo scan 4 0.6 3.26E-04 FLT1, ELL2 vascular endothelial growth factor receptor-1 signaling pathway [BP],
transcription elongation factor complex [CC],
VEGF-B-activated receptor activity [MF],
VEGF-A-activated receptor activity [MF],
placental growth factor-activated receptor activity [MF]
CG_ffipsc1911_promoter_n_RM_12_103_6 logo scan 5 0.8 2.92E-04 PRDM14, LBR, ZNF180, TRERF1, CCBL1, GCH1, EMC8, FANCL, ZNF800, KIAA1161, GBX2 glutamine-phenylpyruvate transaminase activity [MF],
nuclear membrane [CC],
L-phenylalanine:pyruvate aminotransferase activity [MF],
L-phenylalanine-oxaloacetate transaminase activity [MF],
L-glutamine:pyruvate aminotransferase activity [MF],
nuclear envelope [CC],
GTP cyclohydrolase I activity [MF],
7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP],
nucleus [CC]
CG_ffipsc1911_promoter_n_RM_12_117_4 logo scan 5 0.8 3.44E-04 DLG4, HRAS, KCNQ2, SBF2, DENND4A, UFSP1, RAC2 UFM1 hydrolase activity [MF],
Rab guanyl-nucleotide exchange factor activity [MF],
social behavior [BP],
axon guidance [BP],
regulation of long-term neuronal synaptic plasticity [BP],
P2Y1 nucleotide receptor binding [MF]
CG_ffipsc1911_promoter_n_RM_14_28_4 logo scan 4 0.6 2.92E-04 PAX6, TRPT1 forebrain-midbrain boundary formation [BP],
commitment of neuronal cell to specific neuron type in forebrain [BP],
pancreatic A cell development [BP],
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP],
tRNA 2'-phosphotransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_14_3_11 logo scan 4 0.8 4.61E-04 POU3F1, SATB1, ANKH, HOXB3, RXRG, BCL11A, HOXB5, HOXA7, U2AF1, RELN, HOXA1, SLC35D1, TOP2B, NFIB embryonic skeletal system morphogenesis [BP],
embryonic skeletal system development [BP],
glial cell differentiation [BP],
brain development [BP],
central nervous system development [BP],
sequence-specific DNA binding [MF],
sequence-specific DNA binding transcription factor activity [MF],
nucleic acid binding [MF],
negative regulation of gene expression [BP],
forebrain development [BP],
transcription from RNA polymerase II promoter [BP],
rhombomere development [BP],
skeletal system development [BP]
CG_ffipsc1911_promoter_n_RM_12_142_4 logo scan 9 1.0 4.81E-04 GLUL, SHH mesenchymal smoothened signaling pathway involved in prostate gland development [BP],
regulation of mesenchymal cell proliferation involved in prostate gland development [BP],
dynein light chain binding [MF],
positive regulation of skeletal muscle cell proliferation [BP],
negative regulation of kidney smooth muscle cell differentiation [BP],
multicellular structure septum development [BP],
negative regulation of ureter smooth muscle cell differentiation [BP],
positive regulation of ureter smooth muscle cell differentiation [BP],
positive regulation of sclerotome development [BP],
positive regulation of kidney smooth muscle cell differentiation [BP]
CG_ffipsc1911_promoter_n_RM_12_258_6 logo scan 2 0.4 4.15E-04 SLC6A4 negative regulation of cerebellar granule cell precursor proliferation [BP],
serotonin:sodium symporter activity [MF],
cocaine binding [MF]
CG_ffipsc1911_promoter_n_RM_12_173_7 logo scan 4 0.8 3.76E-04 KLK14, JHDM1D histone demethylase activity (H4-K20 specific) [MF],
seminal clot liquefaction [BP],
histone demethylase activity (H3-K27 specific) [MF]
CG_ffipsc1911_promoter_n_RM_12_148_3 logo scan 3 0.6 1.29E-04 ACD, LDB1 transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP],
histone H3-K4 acetylation [BP],
positive regulation of single-stranded telomeric DNA binding [BP]
CG_ffipsc1911_promoter_n_RM_14_1_2 logo scan 5 0.6 4.07E-04 LUZP1 neural fold bending [BP]
CG_ffipsc1911_promoter_n_RM_16_10_2 logo scan 6 0.8 5.04E-04 SOX10, BCL11A, HOXA7, RELN, SATB1, CBX4, TOP2B, UBA3, NFIB protein sumoylation [BP],
glial cell differentiation [BP],
regulation of transcription, DNA-dependent [BP],
negative regulation of transcription, DNA-dependent [BP],
chromatin binding [MF],
negative regulation of gene expression [BP],
regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc1911_promoter_n_RM_12_18_4 logo scan 4 0.8 1.58E-04 OSCP1, MYO1C basal plasma membrane [CC]
CG_ffipsc1911_promoter_n_RM_14_34_1 logo scan 2 0.4 9.95E-04 HOXB1, HOXB5, HOXB3 embryonic skeletal system morphogenesis [BP],
rhombomere 5 development [BP],
facial nerve structural organization [BP],
sequence-specific DNA binding transcription factor activity [MF],
glossopharyngeal nerve morphogenesis [BP],
sequence-specific DNA binding [MF],
anterior/posterior pattern specification [BP],
facial nucleus development [BP],
pattern specification process [BP],
rhombomere 4 development [BP],
rhombomere development [BP]
CG_ffipsc1911_promoter_n_RM_12_70_4 logo scan 6 0.8 3.71E-04 RAB3A synaptic vesicle exocytosis [BP]
CG_ffipsc1911_promoter_n_RM_12_158_4 logo scan 3 0.4 1.40E-04 SLC2A2, NACA negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP],
hexose transmembrane transport [BP],
nascent polypeptide-associated complex [CC]
CG_ffipsc1911_promoter_n_RM_12_240_5 logo scan 5 1.0 2.32E-04 ISG20L2, MSL2, HCFC1, ERI2, PELP1, REXO1, E2F6 exonuclease activity [MF],
MLL1 complex [CC],
histone H4-K16 acetylation [BP]
CG_ffipsc1911_promoter_n_RM_12_35_5 logo scan 4 0.8 4.09E-04 NKX2-5, COL12A1 atrioventricular node cell fate commitment [BP],
proepicardium development [BP],
positive regulation of voltage-gated calcium channel activity [BP],
Purkinje myocyte differentiation [BP],
collagen type XII [CC]
CG_ffipsc1911_promoter_n_RM_12_36_8 logo scan 5 1.0 3.42E-04 ATP5A1, ATP5I mitochondrial ATP synthesis coupled proton transport [BP],
mitochondrial proton-transporting ATP synthase complex [CC]
CG_ffipsc1911_promoter_n_RM_12_64_7 logo scan 6 1.0 4.60E-04 FGFR1, EN1 midbrain development [BP]
CG_ffipsc1911_promoter_n_RM_14_19_2 logo scan 4 0.8 3.21E-04 MYL3, MYO1A, CHRM4 myosin II heavy chain binding [MF],
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway [BP],
myosin complex [CC]
CG_ffipsc1911_promoter_n_RM_12_182_4 logo scan 4 0.8 2.73E-04 WNT11, NKX3-1, SCRIB positive regulation of cell death [BP],
establishment of apical/basal cell polarity [BP],
negative regulation of mitotic cell cycle [BP],
protein kinase activator activity [MF],
salivary gland development [BP]
CG_ffipsc1911_promoter_n_RM_14_22_3 logo scan 2 0.4 2.41E-04 PLXNB1, SIK1, ICMT, WNT3 Spemann organizer formation at the anterior end of the primitive streak [BP],
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF],
cAMP response element binding protein binding [MF],
positive regulation of axonogenesis [BP]
CG_ffipsc1911_promoter_n_RM_16_2_1 logo scan 1 0.2 5.24E-04 MYL3, TBX3 specification of organ position [BP],
myosin II heavy chain binding [MF],
skeletal muscle tissue development [BP],
mammary placode formation [BP],
atrioventricular bundle cell differentiation [BP],
sinoatrial node cell development [BP]
CG_ffipsc1911_promoter_n_RM_12_66_7 logo scan 3 0.6 2.84E-04 DPF3, SMARCC2 nBAF complex [CC]
CG_ffipsc1911_promoter_n_RM_12_286_6 logo scan 6 1.0 2.53E-04 REV3L, TOP1MT, NDUFS1, HMGB2 4 iron, 4 sulfur cluster binding [MF],
DNA topological change [BP]
CG_ffipsc1911_promoter_n_RM_12_150_9 logo scan 3 0.6 3.07E-04 ELAVL1, POLDIP3 positive regulation of translation [BP]
CG_ffipsc1911_promoter_n_RM_14_12_2 logo scan 3 0.4 4.22E-04 ANKLE2, CLCF1 CNTFR-CLCF1 complex [CC],
mitotic nuclear envelope reassembly [BP]
CG_ffipsc1911_promoter_n_RM_12_11_8 logo scan 4 0.8 4.05E-04 TAF4, CLNS1A, TADA3, KAT6A spliceosomal snRNP assembly [BP],
transcription coactivator activity [MF],
histone H3 acetylation [BP],
transcription factor TFTC complex [CC],
histone acetyltransferase activity [MF]
CG_ffipsc1911_promoter_n_RM_12_138_13 logo scan 4 0.8 3.05E-04 PMP22 myelin assembly [BP]